Human macrophages and innate lymphoid cells: Tissue-resident innate immunity in humanized mice.
Animals
CRISPR-Associated Protein 9
/ genetics
CRISPR-Cas Systems
/ genetics
Communicable Diseases
/ genetics
Disease Models, Animal
Gene Editing
Humans
Immunity, Innate
/ genetics
Lymphocytes
/ immunology
Lymphoid Tissue
/ cytology
Macrophages
/ immunology
Mice
Models, Animal
Neoplasms
/ genetics
Species Specificity
CRISPR/Cas9 genome editing
Humanized mice
Innate lymphoid cells
Macrophages
Single-cell RNA-sequencing
Tissue-resident immunity
Journal
Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
19
08
2019
accepted:
15
10
2019
pubmed:
22
10
2019
medline:
25
8
2020
entrez:
22
10
2019
Statut:
ppublish
Résumé
Macrophages and innate lymphoid cells (ILCs) are tissue-resident cells that play important roles in organ homeostasis and tissue immunity. Their intricate relationship with the organs they reside in allows them to quickly respond to perturbations of organ homeostasis and environmental challenges, such as infection and tissue injury. Macrophages and ILCs have been extensively studied in mice, yet important species-specific differences exist regarding innate immunity between humans and mice. Complementary to ex-vivo studies with human cells, humanized mice (i.e. mice with a human immune system) offer the opportunity to study human macrophages and ILCs in vivo within their surrounding tissue microenvironments. In this review, we will discuss how humanized mice have helped gain new knowledge about the basic biology of these cells, as well as their function in infectious and malignant conditions. Furthermore, we will highlight active areas of investigation related to human macrophages and ILCs, such as their cellular heterogeneity, ontogeny, tissue residency, and plasticity. In the near future, we expect more fundamental discoveries in these areas through the combined use of improved humanized mouse models together with state-of-the-art technologies, such as single-cell RNA-sequencing and CRISPR/Cas9 genome editing.
Identifiants
pubmed: 31634458
pii: S0006-2952(19)30371-5
doi: 10.1016/j.bcp.2019.113672
pii:
doi:
Substances chimiques
CRISPR-Associated Protein 9
EC 3.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
113672Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.